Skip to main content
. 2017 Dec 20;7:17949. doi: 10.1038/s41598-017-18186-0

Figure 3.

Figure 3

Modulation of the major survival/death pathways by anti-cancer drugs after ectopic expression of miR-34a in MM cells. RPMI 8226 cells were transfected with miR-34a or miR-NC and treated with γSI, Sirtinol and ZOL, as described in “Methods”. After 48 hours treatment, cells were collected for Western blotting analysis. Subsequently, the expression of SIRT1, p53(Ack 382), NICD, AKT, p-AKT, ERK1/2, p-ERK1/2, pro-Caspases 7, 3, 8 and 9, and their cleaved fragments, were evaluated after blotting with specific antibodies, as described in “Methods” (a/b). Histograms show the variation of protein levels with respect to total proteins, by Image Lab 5.2.1 ChemiDocTM XRS + (BIORAD). The results are shown as the ratio between the active and non-active forms and compared to control cells levels (c). Each experiment was repeated at least three times and data are shown as mean ± standard deviation (SD). *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.